The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Policies & Impacts

House Passes 2 Bills Addressing Nationwide Baby Formula Shortages

House Passes 2 Bills Addressing Nationwide Baby Formula Shortages
Baby formula is offered for sale at a local grocery store in Chicago on May 16, 2022. Baby formula has been in short supply in many stores across the country. Cara Ding/The Epoch Times
Naveen Athrappully
Naveen Athrappully
5/19/2022|Updated: 5/19/2022

The House passed two emergency spending measures on May 18 addressing critical nationwide baby formula shortages.

The main legislation—H.R. 7790, the Infant Formula Supplemental Appropriations Act—seeks to provide the Food and Drug Administration (FDA) with $28 million in “salaries and expenses” for resolving current and future shortages of baby formula.

Naveen Athrappully
Naveen Athrappully
Author
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles

Tesla Fined $243 Million by Florida Jury in Autopilot Crash Lawsuit

Aug 02, 2025
Tesla Fined $243 Million by Florida Jury in Autopilot Crash Lawsuit

US, Russia Space Chiefs Hold First Direct Meeting Since 2018, Vow to Continue Cooperation

Aug 01, 2025
US, Russia Space Chiefs Hold First Direct Meeting Since 2018, Vow to Continue Cooperation

Around 192,000 Kids Play Kitchen Toys Recalled, One Death Reported

Aug 01, 2025
Around 192,000 Kids Play Kitchen Toys Recalled, One Death Reported

FDA Mandates Major Labeling Changes on Opioid Pain Medication

Aug 01, 2025
FDA Mandates Major Labeling Changes on Opioid Pain Medication
Related Topics
Abbott Laboratories
baby formula
Rep. Rosa DeLauro (D-Conn.)
Add to My List
Save
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.